Search Results - "SLACK, Mary P. E"

Refine Results
  1. 1
  2. 2

    Non-typeable Haemophilus influenzae , an under-recognised pathogen by Van Eldere, Johan, Prof, Slack, Mary P E, FRCPath, Ladhani, Shamez, PhD, Cripps, Allan W, PhD

    Published in The Lancet infectious diseases (01-12-2014)
    “…Summary Non-typeable Haemophilus influenzae (NTHi) is a major cause of mucosal infections such as otitis media, sinusitis, conjunctivitis, and exacerbations of…”
    Get full text
    Journal Article
  3. 3

    Pneumococcal carriage in children and adults two years after introduction of the thirteen valent pneumococcal conjugate vaccine in England by van Hoek, Albert Jan, Sheppard, Carmen L, Andrews, Nick J, Waight, Pauline A, Slack, Mary P.E, Harrison, Timothy G, Ladhani, Shamez N, Miller, Elizabeth

    Published in Vaccine (23-07-2014)
    “…Highlights • In April 2010 PCV7 was replaced by PCV13. • We investigated pneumococcal carriage in children and their household contacts. • Carriage of PCV13…”
    Get full text
    Journal Article
  4. 4

    Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study by Miller, Elizabeth, Prof, Andrews, Nicholas J, MSc, Waight, Pauline A, BSc, Slack, Mary PE, FRCPath, George, Robert C, FRCPath

    Published in The Lancet infectious diseases (01-10-2011)
    “…Summary Background The seven-valent pneumococcal conjugate vaccine (PCV7) has reduced vaccine-type (VT) invasive pneumococcal disease but increases in…”
    Get full text
    Journal Article
  5. 5

    Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine by Miller, Elizabeth, Andrews, Nicholas J, Waight, Pauline A, Slack, Mary P.E, George, Robert C

    Published in Vaccine (15-11-2011)
    “…Highlights ► No direct evidence exists for effectiveness of the new serotypes covered by PCV13. ► Efficacy was presumed via a putative serological correlate of…”
    Get full text
    Journal Article
  6. 6

    Using the indirect cohort design to estimate the effectiveness of the seven valent pneumococcal conjugate vaccine in England and Wales by Andrews, Nick, Waight, Pauline A, Borrow, Ray, Ladhani, Shamez, George, Robert C, Slack, Mary P E, Miller, Elizabeth

    Published in PloS one (02-12-2011)
    “…The 7-valent pneumococcal conjugate vaccine (PCV-7) was introduced in the United Kingdom in 2006 with a 2, 3 and 13 month schedule, and has led to large…”
    Get full text
    Journal Article
  7. 7

    Changes in Molecular Epidemiology of Streptococcus pneumoniae Causing Meningitis following Introduction of Pneumococcal Conjugate Vaccination in England and Wales by Pichon, Bruno, Ladhani, Shamez N, Slack, Mary P E, Segonds-Pichon, Anne, Andrews, Nick J, Waight, Pauline A, Miller, Elizabeth, George, Robert

    Published in Journal of Clinical Microbiology (01-03-2013)
    “…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Effects of pneumococcal conjugate vaccines on reducing the risk of respiratory disease associated with coronavirus infection by Dunne, Eileen M, Nunes, Marta C, Slack, Mary P E, Theilacker, Christian, Gessner, Bradford D

    Published in Pneumonia (25-05-2023)
    “…Pneumococcal conjugate vaccines (PCVs) provide protection against vaccine-type pneumococcal disease in both children and adults. Growing evidence suggests that…”
    Get full text
    Journal Article
  10. 10

    Invasive Haemophilus influenzae Type b Disease in England and Wales: Who Is at Risk After 2 Decades of Routine Childhood Vaccination? by Collins, Sarah, Ramsay, Mary, Campbell, Helen, Slack, Mary P. E., Ladhani, Shamez N.

    Published in Clinical infectious diseases (15-12-2013)
    “…Background. The introduction of the Haemophilus influenzae serotype b (Hib) conjugate vaccine into national immunization has led to rapid and sustained…”
    Get full text
    Journal Article
  11. 11

    Impact of the 7-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease in Infants Younger Than 90 Days in England and Wales by Ladhani, Shamez N., Andrews, Nick J., Waight, Pauline, Borrow, Ray, Slack, Mary P. E., Miller, Elizabeth

    Published in Clinical infectious diseases (01-03-2013)
    “…Background. Streptococcus pneumoniae is an uncommon but well-recognized cause of invasive bacterial disease in young infants. This study aimed to determine the…”
    Get full text
    Journal Article
  12. 12
  13. 13

    A review of the role of Haemophilus influenzae in community-acquired pneumonia by Slack, Mary P. E.

    Published in Pneumonia (01-01-2015)
    “…In an era when Haemophilus influenzae type b (Hib) conjugate vaccine is widely used, the incidence of Hib as a cause of community-acquired pneumonia (CAP) has…”
    Get full text
    Journal Article Book Review
  14. 14

    Invasive Pneumococcal Disease, Comorbidities, and Polysaccharide Vaccine Use in Children Aged 5–15 Years in England and Wales by Ladhani, Shamez N., Andrews, Nick J., Waight, Pauline, Borrow, Ray, Slack, Mary P. E., Miller, Elizabeth

    Published in Clinical infectious diseases (15-02-2014)
    “…Background. In the United Kingdom, the 23-valent pneumococcal polysaccharide vaccine (PPV23) is recommended in addition to routine pneumococcal conjugate…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Long-Term Immunological Follow-Up of Children with Haemophilus influenzae Serotype b Vaccine Failure in the United Kingdom by Ladhani, Shamez, Heath, Paul T., Ramsay, Mary E., Slack, Mary P. E., Kibwana, Elizabeth, Pollard, Andrew J., Booy, Robert

    Published in Clinical infectious diseases (01-08-2009)
    “…Background. It is not known how long children with Haemophilus influenzae serotype b (Hib) vaccine failure retain protective Hib antibody concentrations after…”
    Get full text
    Journal Article
  17. 17

    Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and Wales by Andrews, Nick J, Waight, Pauline A, George, Robert C, Slack, Mary P.E, Miller, Elizabeth

    Published in Vaccine (06-11-2012)
    “…Highlights ► A 23 valent pneumococcal conjugate vaccine campaign for ≥65 year olds in England and Wales is assessed. ► Vaccine effectiveness against invasive…”
    Get full text
    Journal Article
  18. 18

    Risk of Invasive Haemophilus influenzae Infection During Pregnancy and Association With Adverse Fetal Outcomes by Collins, Sarah, Ramsay, Mary, Slack, Mary P. E, Campbell, Helen, Flynn, Sally, Litt, David, Ladhani, Shamez N

    “…IMPORTANCE Unencapsulated Haemophilus influenzae frequently causes noninvasive upper respiratory tract infections in children but can also cause invasive…”
    Get full text
    Journal Article
  19. 19

    Effects of PCV10 and PCV13 on pneumococcal serotype 6C disease, carriage, and antimicrobial resistance by Grant, Lindsay R., Hanquet, Germaine, Sepúlveda-Pachón, Ingrid T., Theilacker, Christian, Baay, Marc, Slack, Mary P.E., Jodar, Luis, Gessner, Bradford D.

    Published in Vaccine (30-04-2024)
    “…•Robust PCV13 effect against 6C invasive disease and carriage in children.•PCV13 effects against 6A and 6C invasive disease in children were nearly…”
    Get full text
    Journal Article
  20. 20

    Distribution of serotypes causing invasive pneumococcal disease in older adults from high-income countries and impact of pediatric and adult vaccination policies by Grant, Lindsay R, Slack, Mary P E, Theilacker, Christian, Vojicic, Jelena, Dion, Stéphane, Reinert, Ralf-Rene, Jodar, Luis, Gessner, Bradford D

    Published in Vaccine (31-08-2023)
    “…Neither indirect protection through use of 13-valent and 10-valent pneumococcal conjugate vaccines (PCV13 and PCV10) in pediatric National Immunization…”
    Get full text
    Journal Article